CSL, the country’s largest pharmaceuticals group, has been forced to defend how much it is paying executives after investors delivered a so-called first strike against the remuneration plans ...

Learning how to stop tossing and turning starts with identifying what’s keeping you up and making small adjustments to improve your sleep quality. Say goodbye to restless nights—learn how to ...

But despite the recent dip, many analysts believe CSL shares are undervalued and present a solid long-term investment opportunity. Let's see what the experts say. Several factors have weighed on ...

(RTTNews) - At the Annual General Meeting, Paul McKenzie, Chief Executive Officer of CSL Ltd. (CSL.AX), reaffirmed the company's financial guidance for fiscal year 2025. The company still expects ...

CSL Behring also joined the fight against the coronavirus pandemic this month when its Australian unit started working on a plasma-based therapy for patients with severe forms of COVID-19.

UBS analyst Laura Sutcliffe maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$340.00. The company’s shares closed yesterday at $191.55. According to ...

Shares of building envelope solutions provider Carlisle Companies (NYSE:CSL) fell 8.4% in the morning session after the company reported disappointing third-quarter earnings results. Its revenue ...

View Carlisle Companies Incorporated (CSL) current and estimated P/E ratio data provided by Seeking Alpha.

In a report released yesterday, Steven Wheen from Jarden maintained a Buy rating on CSL (CMXHF – Research Report), with a price target of A$329.62. The company’s shares closed today at $191.55.